Details of the Drug
General Information of Drug (ID: DME0TNA)
| Drug Name |
3-Amino-benzenesulfonamide
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
3-AMINOBENZENESULFONAMIDE; 98-18-0; Metanilamide; m-Aminobenzenesulfonamide; Benzenesulfonamide, 3-amino-; m-Sulfamoylaniline; 3-Aminobenzene-1-Sulfonamide; Benzenesulfonamide, m-amino-; m-Aminobenzenesulphonamide; Metaniilamide; 3-Aminosulfonylaniline; 3-Amino-benzenesulfonamide; NSC 7542; EINECS 202-646-0; BRN 0511851; CHEMBL6852; JPVKCHIPRSQDKL-UHFFFAOYSA-N; MFCD00035781; 3-Sulfanilamide; m-sulfamylaniline; NSC7542; 3-sulfamoyl-aniline; 3-sulfamoyl-phenylamine; 3-aminobenzensulfonamide; AC1Q6UKN; AC1L1OMG
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 172.21 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -0.4 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||||||||||||||
References


